GL1X · GenesisL1 explorer

MolNFT v1 · #65494 · protein

Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridinone inhibitor

3GYN · RNA-directed RNA polymerase: “Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridinone inhibitor”. X-ray diffraction, 1 ligand (B42), 14 pockets (best druggability 0.80). MolNFT v1 #65494 on GenesisL1: 3D…

PDB
3GYN
Type
protein
Length
1,114 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
B42
Pockets
14 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BRNA-directed RNA polymerase (EC 2.7.7.48)protein55749% helix, 15% strandP26663

Ligands and binding sites

  • B42 · N-{3-[(5R)-1-cyclopentyl-4-hydroxy-5-methyl-5-(3-methylbutyl)-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-1,1-dioxido-4H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110730.800.8180B42
211500.800.8193B42
38500.730.7779empty
45370.680.7860empty
51080.490.8017empty

Interfaces

1 interface between chains.

  • A–B · 607 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3GYN · Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridi inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.